“…Recurrent acute pancreatitis increases the risk of developing chronic pancreatitis, and survivors experience reduced long-term quality of life [ [17] , [18] , [19] ]. Core events in acute pancreatitis pathogenesis include pathological calcium signaling, mitochondrial dysfunction, premature activation of proteolytic enzymes, endoplasmic reticulum stress, impaired unfolded protein response, and impaired autophagy [ [20] , [21] , [22] , [24] , [25] , [26] , [27] [20–22,24–27, 23 ]. Inhibition of nuclear factor-kappaB activation, NLRP3 inhibition, restoration of mitochondrial and/or autophagic function, ORAI1 inhibition, inhibition of the RIP1-RIP3 pathway, TNF-alpha inhibition, autophagy pathway inhibition, TLR4 expression suppression, and oxidative stress inhibition have emerged as potential targets or pathways for acute pancreatitis treatment [ [28] , [29] , [30] , [31] , [32] , [33] , [34] , [35] ].…”